Arch Biopartners Inc (ARCH.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 0 | 3,656 | 1,642 | 1,594 | 1,907 |
| Cost of Goods | 0 | 2,916 | 1,078 | 954 | 1,408 |
| Gross Profit | 0 | 740 | 564 | 640 | 499 |
| Operating Expenses | 182 | 1,076 | 797 | 575 | 851 |
| Operating Income | -182 | -335 | -233 | 65 | -352 |
| Interest Expense | N/A | 126 | N/A | N/A | N/A |
| Other Income | 182 | -188 | -126 | -81 | -18 |
| Pre-tax Income | N/A | -650 | -359 | -16 | -369 |
| Income Tax | N/A | 8 | 3 | 2 | 0 |
| Net Income Continuous | -4,656 | -658 | -361 | -18 | -426 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 58 |
| Net Income | $-4,656 | $-658 | $-361 | $-18 | $-369 |
| EPS Basic Total Ops | -0.18 | -0.02 | -0.01 | 0.00 | -0.02 |
| EPS Basic Continuous Ops | -0.18 | -0.02 | -0.01 | 0.00 | -0.02 |
| EPS Diluted Total Ops | -0.18 | -0.02 | -0.01 | 0.00 | -0.02 |
| EPS Diluted Continuous Ops | -0.18 | -0.02 | -0.01 | 0.00 | -0.02 |
| EBITDA(a) | $-182 | $-456 | $-188 | $109 | $-304 |